These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Risk of pocket hematoma in patients on chronic anticoagulation with warfarin undergoing electrophysiological device implantation: a comparison of different peri-operative management strategies. Proietti R, Porto I, Levi M, Leo A, Russo V, Kalfon E, Biondi-Zoccai G, Roux JF, Birnie DH, Essebag V. Eur Rev Med Pharmacol Sci; 2015 Apr; 19(8):1461-79. PubMed ID: 25967723 [Abstract] [Full Text] [Related]
65. Importance of long-term anticoagulation in both prosthetic and biological tricuspid valve replacements. Rafiq I, Freeman LJ, Wood S. Ann Thorac Surg; 2007 Oct; 84(4):1424; author reply 1425. PubMed ID: 17889027 [No Abstract] [Full Text] [Related]
70. Role of heparin in the antithrombotic treatment of valvulopathies. Hanania G. J Heart Valve Dis; 2004 May; 13(3):339-43. PubMed ID: 15222278 [Abstract] [Full Text] [Related]
71. Gains and losses during anticoagulation treatment in patients with mechanical heart valves. Filippatos GS, Gavrielatos G, Kremastinos DT. J Intern Med; 2006 Dec; 260(6):595. PubMed ID: 17116013 [No Abstract] [Full Text] [Related]
73. Implanting cardiac rhythm devices during uninterrupted warfarin therapy: a prospective, single center experience. Crosato M, Calzolari V, Franceschini Grisolia E, Daniotti A, Baldessin F, Mantovan R, Olivari Z. J Cardiovasc Med (Hagerstown); 2015 Jul; 16(7):503-6. PubMed ID: 25022924 [Abstract] [Full Text] [Related]
74. [The follow-up of 12 pregnant women with anticoagulation therapy after mechanical heart valve replacement]. Dong L, Shi Y, Tian Z. Zhonghua Fu Chan Ke Za Zhi; 2001 Aug; 36(8):465-7. PubMed ID: 11758179 [Abstract] [Full Text] [Related]